Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Eastern Cooperative Oncology Group

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 2012-01-01

Employees: 51

Market Cap: -

Website: https://ecog-acrin.org

Clinical Trials

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Phase 3

Active, not recruiting

Conditions: Neurotoxicity
Brain and Central Nervous System Tumors

Interventions: Radiation: 3-dimensional conformal radiation therapy
Drug: temozolomide
Radiation: intensity-modulated radiation therapy

First Posted Date: 2009-09-17

Last Posted Date: 2025-03-17

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 540

Registration Number: NCT00978458

Locations: 🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Arizona Oncology Services Foundation, Phoenix, Arizona, United States
🇺🇸
Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States

and more 165 locations

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

Completed

Conditions: Lymphoma
Leukemia

First Posted Date: 2009-05-12

Last Posted Date: 2023-06-22

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 1873

Registration Number: NCT00897767

Locations: 🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸
Aurora Presbyterian Hospital, Aurora, Colorado, United States

and more 210 locations

Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100

Completed

Conditions: Breast Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2013-04-04

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 500

Registration Number: NCT00899418

Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

Completed

Conditions: Her-2
Pgr
Breast Cancer
Estrogen Receptor

First Posted Date: 2009-05-12

Last Posted Date: 2017-05-17

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 900

Registration Number: NCT00897299

Study of Bone Marrow Samples From Patients With Acute Leukemia

Completed

Conditions: Leukemia

First Posted Date: 2009-05-12

Last Posted Date: 2017-05-17

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 40

Registration Number: NCT00897559

Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2009-05-12

Last Posted Date: 2017-05-17

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 33

Registration Number: NCT00899080

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Phase 2

Withdrawn

Conditions: Prostate Cancer

Interventions: Biological: GVAX prostate cancer vaccine
Drug: bicalutamide
Drug: goserelin
Drug: leuprolide acetate

First Posted Date: 2008-10-10

Last Posted Date: 2023-05-25

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00771017

Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

Phase 2

Completed

Conditions: Melanoma (Skin)

Interventions: Drug: dasatinib

First Posted Date: 2008-06-19

Last Posted Date: 2023-07-03

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 81

Registration Number: NCT00700882

Locations: 🇺🇸
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸
Stanford Cancer Center, Stanford, California, United States
🇺🇸
Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital, Fort Lauderdale, Florida, United States

and more 148 locations

Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer

Phase 2

Withdrawn

Conditions: Prostate Cancer

Interventions: Drug: bicalutamide
Drug: enzastaurin hydrochloride

First Posted Date: 2008-05-28

Last Posted Date: 2013-08-20

Lead Sponsor: Eastern Cooperative Oncology Group

Registration Number: NCT00685633

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Phase 2

Terminated

Conditions: Esophageal Cancer

Interventions: Drug: 5-Fluorouracil
Drug: Oxaliplatin
Drug: Cetuximab
Drug: Docetaxel
Procedure: Surgery
Radiation: Radiotherapy

First Posted Date: 2007-10-31

Last Posted Date: 2023-07-03

Lead Sponsor: Eastern Cooperative Oncology Group

Target Recruit Count: 22

Registration Number: NCT00551759

Locations: 🇺🇸
Tunnell Cancer Center at Beebe Medical Center, Lewes, Delaware, United States
🇺🇸
CCOP - Christiana Care Health Services, Newark, Delaware, United States
🇺🇸
Rush-Copley Cancer Care Center, Aurora, Illinois, United States

and more 106 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy